Kabra Drugs Market Cap ($4.93M USD)
Kabra Drugs Market Cap ($4.93M USD). As of Oct. 5, 2026, Kabra Drugs (KABRADG) market capitalisation is ₹44.35 Cr ($4.93M), with 2.45 Cr shares outstanding at a current price of ₹18.08 on BSE, ranking 3811 out of 5368 companies by market cap in our screener. Kabra Drugs operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see KABRADG stock price BSE.
Market Cap History of Kabra Drugs (Last 10 Years)
KABRADG market capitalisation from year-end BSE closing prices over the last 10 years. Review Kabra Drugs price earnings to evaluate earnings-based valuation against sector peers.
End of Year Market Cap History — Kabra Drugs
KABRADG year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. Compare with KABRADG stock valuation models to assess whether the stock is under or overvalued.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹44.35 Cr
$4.93M USD
|
₹18.08 | BSE | -40.82% |
| 2025 |
₹74.94 Cr
$8.33M USD
|
₹30.55 | BSE | +203.68% |
| 2024 |
₹24.68 Cr
$2.74M USD
|
₹10.06 | BSE | +86.64% |
| 2023 |
₹13.22 Cr
$1.47M USD
|
₹5.39 | BSE | - |